Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers

BACKGROUND. There is robust preclinical literature and preliminary clinical findings supporting the use of N-Acetylcysteine (NAC) to treat substance use disorders, including tobacco use disorder (TUD). However, randomized controlled trials have yielded mixed results and NAC’s efficacy for TUD has no...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Drug Alcohol Depend
Päätekijät: McClure, Erin A., Wahlquist, Amy E., Tomko, Rachel L., Baker, Nathaniel L., Carpenter, Matthew J., Bradley, Elizabeth D., Cato, Patrick A., Gipson, Cassandra D., Gray, Kevin M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282766/
https://ncbi.nlm.nih.gov/pubmed/34171822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2021.108815
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia